0,947  0,001  Antiparkinsonian, rigidity relieving
0,913  0,002  Muscle relaxant
0,892  0,002  Skeletal muscle relaxant
0,821  0,002  Dopamine D2 agonist
0,815  0,003  5 Hydroxytryptamine release stimulant
0,807  0,005  Respiratory analeptic
0,792  0,002  Dopamine D1 antagonist
0,780  0,003  Dopamine agonist
0,768  0,004  Dopamine antagonist
0,761  0,006  Antidepressant
0,755  0,003  5 Hydroxytryptamine 7 antagonist
0,754  0,004  5 Hydroxytryptamine antagonist
0,742  0,003  Alpha 2 adrenoreceptor antagonist
0,740  0,007  Mood disorders treatment
0,729  0,004  Dopamine D2 antagonist
0,710  0,004  5 Hydroxytryptamine 2 antagonist
0,698  0,008  Antiparkinsonian
0,684  0,003  5 Hydroxytryptamine 2A antagonist
0,662  0,003  Sigma receptor agonist
0,662  0,004  Alpha adrenoreceptor antagonist
0,662  0,009  Analeptic
0,650  0,003  Dopamine D5 antagonist
0,646  0,005  Cardiodepressant
0,643  0,005  CYP2D6 inhibitor
0,644  0,012  Antipsychotic
0,617  0,004  5 Hydroxytryptamine 1 antagonist
0,616  0,004  5 Hydroxytryptamine 1A antagonist
0,607  0,005  Male reproductive disfunction treatment
0,606  0,012  Spasmolytic
0,591  0,004  Alpha 2b adrenoreceptor antagonist
0,601  0,014  CYP1A2 substrate
0,614  0,028  CYP3A4 substrate
0,577  0,004  Alpha 2a adrenoreceptor antagonist
0,576  0,004  Erectile dysfunction treatment
0,549  0,003  Dopamine D3 antagonist
0,541  0,019  CYP2D6 substrate
0,536  0,016  CYP2C19 inhibitor
0,547  0,028  CYP2C9 substrate
0,557  0,043  Caspase 9 stimulant
0,531  0,020  Histamine release inhibitor
0,514  0,004  Alpha 2c adrenoreceptor antagonist
0,517  0,009  Psychostimulant
0,487  0,004  Antiparkinsonian, tremor relieving
0,486  0,016  Hypoxia-inducible factor 1 alpha inhibitor
0,472  0,005  Acetylcholine antagonist
0,472  0,005  Cholinergic antagonist
0,498  0,032  Prostate cancer treatment
0,470  0,013  Sedative
0,460  0,003  5 Hydroxytryptamine 5A antagonist
0,496  0,045  Transcription factor NF kappa B inhibitor
0,453  0,006  5 Hydroxytryptamine 2B antagonist
0,473  0,030  Anxiolytic
0,509  0,072  Apoptosis agonist
0,462  0,027  Caspase 3 stimulant
0,447  0,016  Vasodilator
0,433  0,005  Tyrosine 3 hydroxylase inhibitor
0,438  0,016  Antineoplastic enhancer
0,471  0,050  Antineoplastic (lung cancer)
0,418  0,004  5 Hydroxytryptamine 1E antagonist
0,415  0,008  Pneumotoxic
0,426  0,019  Dependence treatment
0,411  0,008  Antiadrenergic
0,402  0,005  Acetylcholine M1 receptor antagonist
0,411  0,015  Cyclic AMP phosphodiesterase inhibitor
0,396  0,003  5 Hydroxytryptamine 5 antagonist
0,425  0,037  Hepatic disorders treatment
0,433  0,047  Cognition disorders treatment
0,438  0,053  Antileukemic
0,390  0,006  Antitussive
0,389  0,005  5 Hydroxytryptamine 1F antagonist
0,388  0,009  Adrenaline antagonist
0,382  0,007  Neurotrophic factor enhancer
0,372  0,003  Restless leg syndrome treatment
0,411  0,052  Vasodilator, peripheral
0,367  0,008  Alpha 1 adrenoreceptor antagonist
0,363  0,005  Acetylcholine nicotinic antagonist
0,362  0,006  5 Hydroxytryptamine agonist
0,387  0,031  DNA damaging
0,375  0,020  Anesthetic general
0,418  0,067  15-Lipoxygenase inhibitor
0,364  0,014  Antineoplastic (squamous cell carcinoma)
0,391  0,043  Antihypertensive
0,357  0,013  Genotoxic
0,346  0,009  Toxic, respiratory center
0,343  0,006  Acetylcholine muscarinic antagonist
0,375  0,040  CYP3A4 inhibitor
0,354  0,021  P-glycoprotein inhibitor
0,339  0,014  Cholinergic
0,335  0,014  Topoisomerase II inhibitor
0,320  0,005  Opioid kappa receptor antagonist
0,314  0,005  Neuronal nicotinic receptor antagonist
0,334  0,028  Abortion inducer
0,313  0,008  Alpha 1a adrenoreceptor antagonist
0,299  0,011  Topoisomerase I inhibitor
0,287  0,003  Antineoplastic alkaloid
0,347  0,066  Antineoplastic (colorectal cancer)
0,340  0,063  Antineoplastic (colon cancer)
0,318  0,042  Mutagenic
0,283  0,009  Antismoking
0,279  0,005  5 Hydroxytryptamine 1B antagonist
0,370  0,098  Analgesic
0,302  0,029  Hepatoprotectant
0,363  0,092  Antineoplastic (breast cancer)
0,278  0,012  LDLR expression enhancer
0,274  0,013  CDC-like kinase 1 inhibitor
0,261  0,004  Alpha 2 adrenoreceptor agonist
0,281  0,025  Antiseptic
0,286  0,030  Antimigraine
0,340  0,086  Prostaglandin dehydrogenase inhibitor
0,270  0,017  Acetylcholinesterase inhibitor
0,262  0,015  Carcinogenic, group 1
0,298  0,052  Antineoplastic (liver cancer)
0,259  0,014  Uterine stimulant
0,249  0,004  Prolactin inhibitor
0,293  0,049  Pyruvate kinase inhibitor
0,331  0,087  Stroke treatment
0,246  0,004  Antiviral (Papilloma)
0,292  0,052  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,248  0,009  Dopamine D4 antagonist
0,255  0,018  Antiviral (Hepatitis B)
0,242  0,005  Acetylcholine M4 receptor antagonist
0,296  0,062  Antihypercholesterolemic
0,305  0,073  Antineoplastic (small cell lung cancer)
0,239  0,009  Calcium antagonist
0,246  0,018  5 Hydroxytryptamine 3E antagonist
0,233  0,006  Alpha adrenoreceptor agonist
0,272  0,046  Antiarrhythmic
0,274  0,048  Anticonvulsant
0,289  0,065  UGT1A9 substrate
0,233  0,009  5 Hydroxytryptamine 1 agonist
0,222  0,005  Phosphodiesterase V inhibitor
0,290  0,074  Antineoplastic (melanoma)
0,220  0,005  Dopamine uptake inhibitor
0,270  0,056  Antineoplastic (glioblastoma multiforme)
0,218  0,005  CDC-like kinase 3 inhibitor
0,255  0,042  Antialcoholic
0,216  0,004  Phosphodiesterase XI inhibitor
0,216  0,004  Phosphodiesterase 11A inhibitor
0,275  0,065  Antipyretic
0,228  0,019  DNA intercalator
0,212  0,004  Nicotinic receptor alpha7 subunit antagonist
0,238  0,030  Antiischemic, cerebral
0,212  0,007  Female sexual dysfunction treatment
0,279  0,076  CYP2C19 substrate
0,212  0,012  Opioid antagonist
0,202  0,004  Nicotinic alpha4beta2 receptor antagonist
0,261  0,066  Acute neurologic disorders treatment
0,273  0,079  Antihypoxic
0,198  0,004  5 Hydroxytryptamine 2 agonist
0,208  0,016  5 Hydroxytryptamine 2C antagonist
0,200  0,009  5 Hydroxytryptamine 1A agonist
0,258  0,068  Dyrk kinase inhibitor
0,195  0,006  Phosphodiesterase 5A inhibitor
0,259  0,071  Antineoplastic (glioma)
0,191  0,003  5 Hydroxytryptamine 3B antagonist
0,222  0,036  Liver fibrosis treatment
0,212  0,028  ATPase inhibitor
0,193  0,010  Opioid mu receptor antagonist
0,248  0,067  Antineoplastic (lymphoma)
0,204  0,025  Alkylator
0,208  0,030  Anesthetic local
0,217  0,039  Antineoplastic (carcinoma)
0,192  0,015  Alpha 1b adrenoreceptor antagonist
0,174  0,003  Dopamine D1 agonist
0,250  0,082  Flavin-containing monooxygenase substrate
0,197  0,030  Psychosexual dysfunction treatment
0,258  0,095  FMO3 substrate
0,233  0,070  Sensitization
0,170  0,010  Sigma receptor antagonist
0,177  0,017  Breast cancer-resistant protein inhibitor
0,264  0,106  Antineoplastic (brain cancer)
0,166  0,008  Alpha 1 adrenoreceptor agonist
0,251  0,096  Cardioprotectant
0,164  0,010  5 Hydroxytryptamine 1D antagonist
0,247  0,094  Radioprotector
0,223  0,072  Antimitotic
0,160  0,010  Acetylcholine M2 receptor antagonist
0,160  0,013  Analgesic, opioid
0,187  0,041  Tubulin antagonist
0,148  0,002  Prolactin release inhibitor
0,160  0,018  Opioid delta receptor antagonist
0,173  0,031  Antiprotozoal (Amoeba)
0,154  0,014  Alpha 1d adrenoreceptor antagonist
0,143  0,004  Nicotinic alpha3beta2 receptor antagonist
0,146  0,007  Opioid mu receptor agonist
0,224  0,090  DNA synthesis inhibitor
0,138  0,007  Opioid kappa receptor agonist
0,145  0,016  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,134  0,007  5 Hydroxytryptamine 2A agonist
0,131  0,004  Dopamine autoreceptor agonist
0,135  0,008  Opioid agonist
0,257  0,133  Antiprotozoal (Plasmodium)
0,154  0,032  Butyrylcholinesterase inhibitor
0,220  0,102  Cardiotonic
0,121  0,005  5 Hydroxytryptamine 7 agonist
0,148  0,032  Constipation treatment
0,120  0,005  5 Hydroxytryptamine 1B agonist
0,249  0,135  Vasodilator, coronary
0,212  0,099  Tumour necrosis factor alpha release inhibitor
0,254  0,142  Calcium channel activator
0,123  0,014  Acetylcholine M3 receptor antagonist
0,126  0,020  Phosphodiesterase 6D inhibitor
0,215  0,112  Antineoplastic (ovarian cancer)
0,172  0,070  Phobic disorders treatment
0,106  0,005  5 Hydroxytryptamine 4 antagonist
0,108  0,009  Nicotinic receptor alpha3 subunit antagonist
0,124  0,025  Acetylcholine nicotinic agonist
0,111  0,015  Acetylcholine M5 receptor antagonist
0,208  0,113  Antiprotozoal (Trypanosoma)
0,123  0,029  Topoisomerase II alpha inhibitor
0,153  0,060  Anesthetic
0,199  0,107  Antineoplastic (non-small cell lung cancer)
0,159  0,068  UGT2B9 substrate
0,109  0,018  Narcotic antagonist
0,098  0,008  Nicotinic receptor alpha4 subunit antagonist
0,100  0,012  Dopamine transporter inhibitor
0,154  0,067  Antidiarrheal
0,097  0,012  Glutamate (mGluR7) antagonist
0,106  0,021  Calcium channel L-type blocker
0,214  0,130  Antiischemic
0,185  0,102  Teratogen
0,099  0,018  5 Hydroxytryptamine 3 antagonist
0,112  0,032  Phosphodiesterase I inhibitor
0,124  0,045  Nav1.1 sodium channel blocker
0,105  0,028  mTOR complex 2 inhibitor
0,114  0,037  Carcinogenic, group 2A
0,281  0,206  Antineoplastic (solid tumors)
0,191  0,117  Antineoplastic (renal cancer)
0,159  0,085  Aldehyde oxidase substrate
0,082  0,010  5 Hydroxytryptamine 2C agonist
0,089  0,019  5 Hydroxytryptamine 6 antagonist
0,097  0,027  5 Hydroxytryptamine uptake inhibitor
0,153  0,085  UGT2B7 substrate
0,121  0,053  Sphingosine 1-phosphate receptor 2 agonist
0,166  0,101  Clk dual-specificity kinase inhibitor
0,171  0,105  Embryotoxic
0,073  0,010  Factor III inhibitor
0,206  0,145  12-Lipoxygenase inhibitor
0,099  0,038  Antiviral (Hepatitis A)
0,065  0,005  Phosphodiesterase 6C inhibitor
0,174  0,118  Antiprotozoal (Leishmania)
0,098  0,042  ATPase (Vacuolar H+) inhibitor
0,115  0,059  Activin receptor-like kinase 4 inhibitor
0,100  0,046  Histamine N-methyltransferase inhibitor
0,129  0,076  CNS active muscle relaxant
0,057  0,005  Phosphodiesterase 6B inhibitor
0,095  0,045  Tocolytic
0,164  0,114  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,065  0,015  Potassium channel small-conductance Ca-activated blocker
0,257  0,209  Alzheimer's disease treatment
0,084  0,036  Phosphodiesterase VI inhibitor
0,126  0,078  Cocaine dependence treatment
0,192  0,146  Antiepileptic
0,143  0,097  Cystic fibrosis treatment
0,169  0,124  Antineoplastic (cervical cancer)
0,136  0,092  Heat shock protein 70 antagonist
0,071  0,027  Nicotinic neuronal receptor agonist
0,068  0,025  Nicotinic alpha7 receptor agonist
0,075  0,031  5 Hydroxytryptamine 3 agonist
0,229  0,185  Antiprotozoal
0,121  0,079  Papain-like protease (SARS coronavirus) inhibitor
0,083  0,041  Antidote, organophosphates
0,136  0,095  UGT1A3 substrate
0,072  0,031  Antiviral (Parainfluenza)
0,088  0,049  Antiprotozoal activity enhancer
0,063  0,028  Melanin-concentrating hormone receptor 1 antagonist
0,152  0,117  UGT1A1 substrate
0,110  0,076  Menstruation disorders treatment
0,048  0,014  Vesicle monoamine transporter inhibitor
0,138  0,107  Nitric oxide antagonist
0,128  0,098  MAP3K9 inhibitor
0,035  0,005  Phosphodiesterase 6G inhibitor
0,035  0,005  Phosphodiesterase 6H inhibitor
0,046  0,016  Opioid delta receptor agonist
0,087  0,058  Acetylcholine agonist
0,041  0,012  Endothelin receptor antagonist
0,061  0,034  Ryanodine receptor antagonist
0,162  0,135  VEGF expression inhibitor
0,047  0,021  Dopamine D3 agonist
0,057  0,033  Alpha tubulin antagonist
0,210  0,186  Immunosuppressant
0,030  0,009  Endothelin B receptor antagonist
0,061  0,039  Phosphodiesterase 1A inhibitor
0,067  0,047  Acetylcholine M5 receptor agonist
0,095  0,074  Expectorant
0,102  0,082  Adenylate cyclase inhibitor
0,117  0,097  Lipid peroxidase inhibitor
0,137  0,118  Sleep disorders treatment
0,191  0,172  5 Hydroxytryptamine uptake stimulant
0,186  0,168  Bone diseases treatment
0,033  0,016  Nicotinic alpha3beta4 receptor agonist
0,031  0,015  5 Hydroxytryptamine 6 agonist
0,074  0,058  Antitreponemal
0,031  0,016  Nicotinic alpha4beta2 receptor agonist
0,148  0,133  HERG channel blocker
0,026  0,012  Endothelin A receptor antagonist
0,113  0,100  Antifungal enhancer
0,065  0,052  Premenstrual syndrome treatment
0,049  0,036  Dopamine D4 agonist
0,154  0,141  NOS2 expression inhibitor
0,069  0,056  Glutamate decarboxylase inhibitor
0,127  0,116  Carcinogenic
0,025  0,013  Phosphodiesterase 6A inhibitor
0,111  0,100  Attention deficit/hyperactivity disorder treatment
0,095  0,086  DOPA decarboxylase inhibitor
0,038  0,029  5 Hydroxytryptamine 2B agonist
0,021  0,013  Imidazoline I1 receptor antagonist
0,090  0,084  Estrogen receptor beta antagonist
0,014  0,012  NMDA receptor phencyclidine site antagonist
0,063  0,061  Telomerase inhibitor
0,107  0,105  Calcium channel blocker
0,017  0,015  Vesicular acetylcholine transporter inhibitor
0,026  0,025  HCV NS5A inhibitor
0,131  0,130  Platelet adhesion inhibitor

